411 related articles for article (PubMed ID: 31139075)
1. NMDA Receptor Antagonist Effects on Speech-Related Mismatch Negativity and Its Underlying Oscillatory and Source Activity in Healthy Humans.
de la Salle S; Shah D; Choueiry J; Bowers H; McIntosh J; Ilivitsky V; Knott V
Front Pharmacol; 2019; 10():455. PubMed ID: 31139075
[TBL] [Abstract][Full Text] [Related]
2. Rodent Mismatch Negativity/theta Neuro-Oscillatory Response as a Translational Neurophysiological Biomarker for N-Methyl-D-Aspartate Receptor-Based New Treatment Development in Schizophrenia.
Lee M; Balla A; Sershen H; Sehatpour P; Lakatos P; Javitt DC
Neuropsychopharmacology; 2018 Feb; 43(3):571-582. PubMed ID: 28816240
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cerebral type 1 cannabinoid receptors is associated with impaired auditory mismatch negativity generation in the ketamine model of schizophrenia.
Roser P; Haussleiter IS; Chong HJ; Maier C; Kawohl W; Norra C; Juckel G
Psychopharmacology (Berl); 2011 Dec; 218(4):611-20. PubMed ID: 21590281
[TBL] [Abstract][Full Text] [Related]
4. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
Hamilton HK; D'Souza DC; Ford JM; Roach BJ; Kort NS; Ahn KH; Bhakta S; Ranganathan M; Mathalon DH
Schizophr Res; 2018 Jan; 191():87-94. PubMed ID: 28711472
[TBL] [Abstract][Full Text] [Related]
5. Mismatch Negativity and Theta Oscillations Evoked by Auditory Deviance in Early Schizophrenia.
Hua JPY; Roach BJ; Ford JM; Mathalon DH
Biol Psychiatry Cogn Neurosci Neuroimaging; 2023 Dec; 8(12):1186-1196. PubMed ID: 36931469
[TBL] [Abstract][Full Text] [Related]
6. The effects of ketamine on the mismatch negativity (MMN) in humans - A meta-analysis.
Rosburg T; Kreitschmann-Andermahr I
Clin Neurophysiol; 2016 Feb; 127(2):1387-1394. PubMed ID: 26699665
[TBL] [Abstract][Full Text] [Related]
7. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.
Umbricht D; Schmid L; Koller R; Vollenweider FX; Hell D; Javitt DC
Arch Gen Psychiatry; 2000 Dec; 57(12):1139-47. PubMed ID: 11115327
[TBL] [Abstract][Full Text] [Related]
8. Glutamatergic deficit and schizophrenia-like negative symptoms: new evidence from ketamine-induced mismatch negativity alterations in healthy male humans.
Thiebes S; Leicht G; Curic S; Steinmann S; Polomac N; Andreou C; Eichler I; Eichler L; Zöllner C; Gallinat J; Hanganu-Opatz I; Mulert C
J Psychiatry Neurosci; 2017 Jun; 42(4):273-283. PubMed ID: 28556775
[TBL] [Abstract][Full Text] [Related]
9. Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers.
Umbricht D; Koller R; Vollenweider FX; Schmid L
Biol Psychiatry; 2002 Mar; 51(5):400-6. PubMed ID: 11904134
[TBL] [Abstract][Full Text] [Related]
10. Effects of nicotine on the neurophysiological and behavioral effects of ketamine in humans.
Mathalon DH; Ahn KH; Perry EB; Cho HS; Roach BJ; Blais RK; Bhakta S; Ranganathan M; Ford JM; D'Souza DC
Front Psychiatry; 2014; 5():3. PubMed ID: 24478731
[TBL] [Abstract][Full Text] [Related]
11. Auditory discrimination profiles of speech sound changes in 6-year-old children as determined with the multi-feature MMN paradigm.
Lovio R; Pakarinen S; Huotilainen M; Alku P; Silvennoinen S; Näätänen R; Kujala T
Clin Neurophysiol; 2009 May; 120(5):916-21. PubMed ID: 19386542
[TBL] [Abstract][Full Text] [Related]
12. Spectral and phase-coherence correlates of impaired auditory mismatch negativity (MMN) in schizophrenia: A MEG study.
Sauer A; Grent-'t-Jong T; Zeev-Wolf M; Singer W; Goldstein A; Uhlhaas PJ
Schizophr Res; 2023 Nov; 261():60-71. PubMed ID: 37708723
[TBL] [Abstract][Full Text] [Related]
13. Auditory Mismatch Negativity and P300a Elicited by the "Optimal" Multi-feature Paradigm in Early Schizophrenia.
Fisher DJ; Campbell DJ; Abriel SC; Ells EML; Rudolph ED; Tibbo PG
Clin EEG Neurosci; 2018 Jul; 49(4):238-247. PubMed ID: 29502452
[TBL] [Abstract][Full Text] [Related]
14. Differential of Frequency and Duration Mismatch Negativity and Theta Power Deficits in First-Episode and Chronic Schizophrenia.
Xiong YB; Bo QJ; Wang CM; Tian Q; Liu Y; Wang CY
Front Behav Neurosci; 2019; 13():37. PubMed ID: 30894804
[No Abstract] [Full Text] [Related]
15. Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.
Heekeren K; Daumann J; Neukirch A; Stock C; Kawohl W; Norra C; Waberski TD; Gouzoulis-Mayfrank E
Psychopharmacology (Berl); 2008 Jul; 199(1):77-88. PubMed ID: 18488201
[TBL] [Abstract][Full Text] [Related]
16. Atypical central auditory speech-sound discrimination in children who stutter as indexed by the mismatch negativity.
Jansson-Verkasalo E; Eggers K; Järvenpää A; Suominen K; Van den Bergh B; De Nil L; Kujala T
J Fluency Disord; 2014 Sep; 41():1-11. PubMed ID: 25066139
[TBL] [Abstract][Full Text] [Related]
17. Effects of recurrent acute otitis media on cortical speech-sound processing in 2-year old children.
Haapala S; Niemitalo-Haapola E; Raappana A; Kujala T; Suominen K; Kujala T; Jansson-Verkasalo E
Ear Hear; 2014; 35(3):e75-83. PubMed ID: 24370565
[TBL] [Abstract][Full Text] [Related]
18. Reduction of phonetic mismatch negativity may depict illness course and predict functional outcomes in schizophrenia.
Mi L; Wang L; Li X; She S; Li H; Huang H; Zhang J; Liu Y; Zhao J; Ning Y; Zheng Y
J Psychiatr Res; 2021 May; 137():290-297. PubMed ID: 33735719
[TBL] [Abstract][Full Text] [Related]
19. Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia.
Javitt DC; Lee M; Kantrowitz JT; Martinez A
Schizophr Res; 2018 Jan; 191():51-60. PubMed ID: 28666633
[TBL] [Abstract][Full Text] [Related]
20. The right profile: mismatch negativity in schizophrenia with and without auditory hallucinations as measured by a multi-feature paradigm.
Fisher DJ; Labelle A; Knott VJ
Clin Neurophysiol; 2008 Apr; 119(4):909-21. PubMed ID: 18261954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
